tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Ravi Misra, 2 are a BUY (40%), 2 are a HOLD (40%), 1 are a SELL (20%).
Analyst Ravi Misra, carries an average stock price target met ratio of 83.33% that have a potential upside of 16.45% achieved within 98 days. Previously, Ravi Misra worked at BERENBERG.
Ravi Misra’s has documented 19 price targets and ratings displayed on 3 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on TDOC, Teladoc at 01-Nov-2022.
Analyst best performing recommendations are on TDOC (TELADOC).
The best stock recommendation documented was for TDOC (TELADOC) at 11/1/2022. The price target of $33 was fulfilled within 10 days with a profit of $4.12 (14.27%) receiving and performance score of 14.27.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$190
$40.43 (27.03%)
$250
28 days ago
(31-Jul-2025)
14/38 (36.84%)
$60.99 (47.28%)
93
Buy
$200
$50.43 (33.72%)
$275
28 days ago
(31-Jul-2025)
27/40 (67.5%)
$70.99 (55.03%)
148
Buy
$220
$70.43 (47.09%)
$200
1 months 19 days ago
(09-Jul-2025)
6/15 (40%)
$19.52 (9.74%)
239
Buy
$245
$95.43 (63.80%)
$250
3 months 30 days ago
(29-Apr-2025)
11/13 (84.62%)
$67.25 (37.83%)
332
Hold
$215
$65.43 (43.75%)
$230
4 months 4 days ago
(24-Apr-2025)
10/17 (58.82%)
$30.73 (16.68%)
123
What Year was the first public recommendation made by Ravi Misra?
